VARIPULSE Bi-Directional Ablation Catheter REF D141201. The Field Catheter is indicated for...

FDA Device Recall #Z-1205-2025 — Class I — January 5, 2025

Recall Summary

Recall Number Z-1205-2025
Classification Class I — Serious risk
Date Initiated January 5, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Biosense Webster, Inc.
Location Irvine, CA
Product Type Devices
Quantity 497 total catheter - 378 US and 119 OUS

Product Description

VARIPULSE Bi-Directional Ablation Catheter REF D141201. The Field Catheter is indicated for use in catheter based cardiac electrophysiological mapping (stimulating and recording) and, when used for TRUPULSE Generator, for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The catheter provides location information when used with the CARTO 3 System.

Reason for Recall

Due to an observed trend of neurovascular events

Distribution Pattern

Worldwide distribution; US states of AR, CA, CO, KS, LA, MA, MO, NY, OH and TX. EMEA, New Zealand, Saudi Arabia, Oman, United Ecuador, Panama, South Africa, China Austria Belgium Czech Republic France Germany Hungary Ireland Israel Italy UK Sweden Norway Denmark Finland Luxembourg Netherlands Poland Portugal Slovenia Spain Switzerland Serbia United Arab Emirates Croatia Canada South Korea Japan

Lot / Code Information

Product Number: D141201-12 UDI-DI code: 10846835025460 Batch Numbers: 31483574L 31483560L 31483581L 31483542L 31487313L 31483552L 31483544L 31487311L 31483550L 31483558L 31483575L 31483556L 31487312L 31483553L 31483565L 31483576L 31483547L 31487320L 31483549L 31483561L 31483548L 31483564L 31483541L 31483546L 31483562L 31483566L 31483583L 31483567L

Other Recalls from Biosense Webster, Inc.

Recall # Classification Product Date
Z-1290-2024 Class II CARTO VIZIGO Bi-Directional Guiding Sheath, RE... Feb 16, 2024
Z-1320-2023 Class II Biosense Webster Carto Vizigo Bi-Directional Gu... Feb 21, 2023
Z-1319-2023 Class II Biosense Webster Carto Vizigo Bi-Directional Gu... Feb 21, 2023
Z-1677-2022 Class II CARTO VIZIGO 8.5F Bi-Directional Guiding Sheath... Jun 29, 2022
Z-1287-2021 Class II Biosense Webster, CARTO VIZIGO, Bi-Directional ... Feb 26, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.